CUSTOMER STORY
Driving 75% of Prescriptions and Reallocated
Marketing Spend
Solution area
Thereupeutic area
Company
A U.S.-based biopharma company focused on gastrointestinal disorders recently launched a first-in-class therapy. As treatment began reaching physicians and early prescribing picked up, the commercial team moved into the next stage of the launch.
CHALLENGES
After the launch, momentum was building. The commercial team now faced the central question: How should the next marketing dollars be allocated to drive prescriptions most effectively?
Several factors made that decision difficult.
Limited budget with high stakes
Promotional dollars had to be allocated quickly across sales reps, digital campaigns, speaker programs, and sampling without overspending in already saturated channels.
Too many channels and unclear contribution
Sales outreach, digital engagement, DTC campaigns, and congress activity often reached the same physicians, making it difficult to identify what actually drove prescriptions.
No historical playbook
As a first-in-class therapy, there were very few benchmarks for how quickly physicians would adopt the treatment.
Strong opinions, but limited evidence
Sales and marketing teams had perspectives on what was working, but the executive team lacked a clear, data-backed view of where to allocate additional investment.
Our Approach
To pinpoint where marketing investment influenced prescribing, the Beghou team collaborated with commercial and analytics teams to link promotional activity directly to prescribing behavior.
IMPACT
75% of prescriptions were linked to measurable promotional activity
Executive and marketing teams gained direct insight into the impact of
marketing investment on physician adoption.
The channels driving prescription growth became clear
Sales force engagement, targeted digital HCP outreach, and select DTC tactics
emerged as the strongest contributors to prescribing activity. This allowed the
marketing teams to focus investment where it was most likely to generate lift.
Areas of diminishing returns were identified
Several marketing channels were already approaching saturation, allowing the team
to avoid additional spending where incremental investment would have produced
limited impact.
Vendor and channel shifts unlocked major reallocation opportunities
Investment could increase by up to 50% with high-performing vendors while reducing
spend with lower-performing partners without jeopardizing performance.
Are your commercial investments delivering the results you expect?
Beghou combines structured, data-centric analysis with deep industry experience to help you identify where strategy is working and maximize your ROI.